Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
酶学 肿瘤
/
酶制剂
免疫/炎症 酶抑制剂 肿瘤发展和微环境演变
/
环氧合酶抑制剂
环氧化酶 环氧合酶
/ Sulindac/舒林酸

Sulindac/舒林酸 {[allProObj[0].p_purity_real_show]}

货号：A253022 同义名： MK-231

Sulindac是一种非类固醇抗炎药（NSAID），被认为作用于COX-1和COX-2酶，抑制前列腺素合成。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Sulindac/舒林酸 化学结构 CAS号：38194-50-2
Sulindac/舒林酸 化学结构
CAS号：38194-50-2
Sulindac/舒林酸 3D分子结构
CAS号：38194-50-2
Sulindac/舒林酸 化学结构 CAS号：38194-50-2
Sulindac/舒林酸 3D分子结构 CAS号：38194-50-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} 		{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Sulindac/舒林酸 纯度/质量文件 产品仅供科研

货号：A253022 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
• Cell, 2025. Ambeed. [ A122167 ]
• Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
• Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
• Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 COX ↓ COX-1 ↓ COX-2 ↓ 其他靶点 纯度
Piroxicam ✔ 98%
Salicylic acid ✔ 98%
Phenacetin ✔ 98%
Etodolac ✔ 99%
Flunixin meglumine ✔ 98%
Ibuprofen L-lysine ✔ 98%
Nabumetone ✔ 98%
Acemetacin ✔ 98%
Diflunisal ✔ 98%
Pranoprofen ✔ 98%
Ampiroxicam ✔ 98%
Meloxicam ✔ 98%
Sulindac ✔ 98%
Ketoprofen ✔ 98%
Mefenamic Acid ✔ 95%
Bromfenac sodium ✔ 98%
Oxaprozin ✔ 99%
Aspirin ✔ 99%
Nepafenac ✔ 98%
Zaltoprofen ✔ 99%
Salicin ✔ 98%
Suprofen ✔ 99%+
Xanthohumol ✔ 99%
Parecoxib ✔ 98%
Tolfenamic Acid +++

COX-2, IC50: 0.2 μM

 		98%
Etoricoxib ✔ 99%
Niflumic Acid ✔ 98%
Valdecoxib ++++

COX-2, IC50: 5 nM

 		99+%
Ibuprofen +

COX-1, IC50: 13 μM

 		+

COX-2, IC50: 370 μM

 		98%
Indomethacin ++

COX1, IC50: 0.28 μM

 		+

COX-2, IC50: 14 μM

 		97%
Lornoxicam ++++

COX-1, IC50: 5 nM

 		++++

COX-2, IC50: 8 nM

 		98%
Meclofenamic acid sodium ++++

COX-1, IC50: 40 nM

 		+++

COX-2, IC50: 50 nM

 		99%
Asaraldehyde ✔ 98%
Naproxen +

COX-1, IC50: 8.7 μM

 		+

COX-2, IC50: 5.2 μM

 		98%
Diclofenac Sodium Salt +++

COX-1, IC50: 60 nM

 		+++

COX-2, IC50: 200 nM

 		98%
NS-398 ++

COX-2, IC50: 3.8 μM

 		95%
Amfenac Sodium Hydrate ++

COX-1, IC50: 250 nM

 		+++

COX-2, IC50: 150 nM

 		98%+
Nimesulide +

COX-2, IC50: 26 μM

 		98%
Lumiracoxib ++

COX-1, Ki: 3 μM

 		+++

COX-2, Ki: 60 nM

 		98%
Rutaecarpine ✔ 95%
Celecoxib ++++

COX-2, IC50: 40 nM

 		98%
Carprofen ++++

canine COX2, IC50: 30 nM

 		98%
Ketorolac ++

COX-1 (human), IC50: 1.23 μM

 		++

COX-2 (human), IC50: 3.50 μM

 		98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Sulindac/舒林酸 生物活性

靶点

  • COX
描述 Sulindac is a non-steroidal antiinflammatory agent, acts as a COX-2 inhibitor, and inhibits overexpression of COX-2. Treatment with sulindac not only inhibited tumor formation but decreased small bowel Cox-2 and prostaglandin E(2) to baseline and restored normal levels of apoptosis[3]. Sulindac (0.1 mM to 0.5 mM) causes limited death in both p53 wt and p53 null HCT116 cells, but in combination with vitamin C, it dramatically increases almost 5-fold in cell death in p53 wt HCT116 cells relative to the vitamin C alone, and such an effect is involving caspase activation and p53 function in these cells, and via ROS-mediated pathway. Sulindac combined with vitamin C significantly increases PUMA levels, but shows no effect on Bim, Bcl-2 and Mcl-1 levels[4]. Moreover, celecoxib and sulindac can inhibit TGF-β1-induced EMT (epithelial-mesenchymal transition) and suppress lung cancer cell migration and invasion via downregulation of SIRT1(class III deacetylase sirtuin 1) [5]. Sulindac can protect normal astrocytes against oxidative stress. Sulindac induces differentiation of both NSC ( neural stem cells) and GSC (glioblastoma stem cells) cells and sulindac upregulates neurogenesis in NSC. The differentiated NSC are also protected from oxidative stress damage, whereas the differentiation of GSC by sulindac increases the sensitivity of these cells to agents that cause oxidative stress[6].

Sulindac/舒林酸 细胞实验

Cell Line
Concentration Treated Time Description References
human colon cancer cell lines (HCCC) 70–79.3 µM 24 h To study the effect of P-S on cell growth, P-S significantly inhibited cell proliferation and induced apoptosis. Gastroenterology. 2010 Oct;139(4):1320-32.
NCM460 cells 100 µM 24 h P-S showed lower toxicity to normal colon epithelial cells NCM460, indicating its selectivity for cancer cells. Gastroenterology. 2010 Oct;139(4):1320-32.
GABAergic neurons 20 μM 2 days Sulindac selectively induced apoptosis of GABAergic neurons, leading to hyperactive behavior in zebrafish larvae. Nat Commun. 2023 Sep 2;14(1):5351.
PDO-AGR 5 nM 48 h K-80003 enhanced the sensitivity to AG chemotherapy, significantly shrinking tumors and prolonging median survival. Mol Cancer. 2024 Sep 30;23(1):215.
HCT116 100 μM 36 h SS inhibits the growth of HCT116 cells and causes G1 phase cell cycle arrest. Genes Dis. 2020 Nov 16;8(3):320-330.
HT29 100 μM 36 h SS inhibits the growth of HT29 cells and causes G1 phase cell cycle arrest. Genes Dis. 2020 Nov 16;8(3):320-330.
HEK 293T 5, 12.5, 25, 50, 75 µM 24 h SS significantly inhibited Notch1 and APP C99 cleavage, but SF had a very modest effect. Front Immunol. 2023 Oct 13;14:1244159.
H4 25, 50, 75, 100 µM 24 h SS inhibited the cleavage of Notch1 and APP-C99 in a dose-dependent manner. Front Immunol. 2023 Oct 13;14:1244159.
MDA-MB-231 10, 25, 50, 100 µM 48 h SS inhibited the γ-secretase mediated release of the intracellular cytoplasmic domains of Notch1. Front Immunol. 2023 Oct 13;14:1244159.
MDA-MB-231 5, 10, 25, 50, 100 µM 1 week SS inhibited mammosphere growth in MDA-MB-231 cells in a dose-dependent manner. Front Immunol. 2023 Oct 13;14:1244159.
C0321 5, 10, 25, 50, 100 µM 1 week SS inhibited mammosphere growth in C0321 cells in a dose-dependent manner. Front Immunol. 2023 Oct 13;14:1244159.
2K1 PDX 5, 10, 25, 50, 100 µM 1 week SS dose-dependently decreased mammosphere growth in 2K1 PDX. Front Immunol. 2023 Oct 13;14:1244159.

Sulindac/舒林酸 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice ZIKV-infected mouse model Intraperitoneal injection 20 mg/kg From 5 dpi till euthanasia or death Sulindac, as an S100A4 inhibitor, was tested for its protective effects on ZIKV-induced testicular damage. The results showed that Sulindac was less effective than Niclosamide in inhibiting S100A4 expression. Nat Commun. 2023 Apr 29;14(1):2476
Mice Apcmin/+ mouse model Oral gavage 30 mg/kg Once daily for 3 weeks To evaluate the effects of Sulindac alone and in combination with phosphatidylcholine (PC) on intestinal polyp burden in mice. Results showed that both Sulindac and Sulindac-PC significantly reduced polyp counts, and Sulindac-PC reduced gastric lesions. BMC Cancer. 2020 Sep 10;20(1):871
Mice Min mouse model Intraperitoneal injection 1.875 mg/kg Twice daily for 45 days Sulindac was used as a positive control for tumour inhibition. In the single-agent study, Sulindac was less effective than MMPI or COX-2I, but still showed some tumour inhibition in the Min mouse model. Br J Cancer. 2003 May 6;88(9):1445-52
Mice Apc/Min mice Oral 100 mg/kg/d Once daily for 28 days P-S significantly reduced the number of intestinal tumors in Apc/Min mice, demonstrating significant anticancer effects. Gastroenterology. 2010 Oct;139(4):1320-32.
Mice KM mice Gastric feeding 26 mg/kg, 52 mg/kg, 104 mg/kg Once daily for 30 days Long-term administration of sulindac led to hyperactivity in mice and induced apoptosis of neocortical GABAergic neurons. Nat Commun. 2023 Sep 2;14(1):5351.
Mice PDOX model Intraperitoneal injection 20 mg/kg Twice weekly for 3 weeks K-80003 significantly shrank tumors and prolonged median survival in vivo, with no significant drug toxicity observed. Mol Cancer. 2024 Sep 30;23(1):215.
Mice C0321 TNBC model Oral 60 mg/kg Daily for 14 days SS significantly delayed tumor growth and reduced tumor mass without altering body mass. Front Immunol. 2023 Oct 13;14:1244159.

Sulindac/舒林酸 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00275756 Glaucoma Not Applicable Withdrawn - Austria ... 展开 >> Department of Clinical Pharmacology Vienna, Austria, A-1090 收起 <<
NCT00283803 - Completed - -
NCT02003703 Hepatitis B H... 展开 >>IV 收起 << Phase 3 Recruiting - Chile ... 展开 >> Hospital Gustavo Fricke Recruiting Viña del Mar, Valparaíso, Chile Contact: Jose I Vargas, MD    62473415 ext +56 9    jivargasd@icloud.com    Contact: Daniela Jensen, MD    62473409 ext +56 9    daniela_jensen@hotmail.com    Principal Investigator: Jose I Vargas, MD          Principal Investigator: Daniela Jensen, MD          Principal Investigator: Francisco Fuster, MD          Principal Investigator: Valeska Sarmiento 收起 <<

Sulindac/舒林酸 参考文献

[1]Yamamoto Y, Yin MJ, et al. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem. 1999 Sep 17;274(38):27307-14.

[2]Piazza GA, Rahm AL, et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 1995 Jul 15;55(14):3110-6.

[3]Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 1996;56(11):2556-2560

[4]Gong EY, Shin YJ, Hwang IY, et al. Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells. Toxicol Lett. 2016;258:126-133

[5]Cha BK, Kim YS, Hwang KE, et al. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1. Oncotarget. 2016;7(35):57213-5722

[6]Allani SK, Weissbach H, Lopez Toledano MA. Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress. Neoplasma. 2018;65(3):376-388

Sulindac/舒林酸 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.81mL

0.56mL

0.28mL

14.03mL

2.81mL

1.40mL

28.06mL

5.61mL

2.81mL

Sulindac/舒林酸 技术信息

CAS号38194-50-2
分子式C20H17FO3S
分子量 356.41
SMILES Code O=C(CC(C1=C2C=CC(F)=C1)=C(/C2=C/C3=CC=C(C=C3)S(C)=O)C)O
MDL No. MFCD00599589
别名 MK-231
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, store in freezer, under -20°C
溶解方案

DMSO: 50 mg/mL(140.29 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液，再依次添加助溶剂：
——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议现用现配，当天使用； 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶
方案 一
方案 二

Tags: Sulindac | 38194-50-2 | MK-231 | MK231 | MK 231 | NF-κB | Immunology/Inflammation | NF-κB | PD-1/PD-L1 | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Sulindac/舒林酸 纯度/质量文件 | Sulindac/舒林酸 亚型比较 | Sulindac/舒林酸 生物活性 | Sulindac/舒林酸 临床数据 | Sulindac/舒林酸 参考文献 | Sulindac/舒林酸 实验方案 | Sulindac/舒林酸 技术信息

AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 AmBeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z